Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Association between cytokine levels and disease relapse in newly diagnosed childhood-onset primary nephrotic syndrome.

Created on 29 Aug 2026

Authors

Chenxi Wei, Chang Zheng, Tingyu Shen, Lijun Jiang, Xingjie Qi, Zanhua Rong

Published in

Frontiers in pediatrics. Volume 14. Pages 1910298. Epub Aug 14, 2026.

Abstract

Although most pediatric patients with primary nephrotic syndrome (PNS) are steroid-sensitive, some develop steroid dependence and experience disease relapse. Therefore, identifying risk factors associated with PNS relapse is clinically important.
This retrospective study included 74 children with newly diagnosed PNS and 39 healthy children as controls. Patients with PNS were classified into relapse and non-relapse groups according to whether relapse occurred within 6 months after disease onset. Serum cytokine levels and peripheral blood lymphocyte subsets were measured using enzyme-linked immunosorbent assays and flow cytometry, respectively.
Demographic characteristics and laboratory findings did not differ significantly between male and female children with PNS. Compared with healthy controls, patients with PNS exhibited abnormal white blood cell and platelet counts, an elevated erythrocyte sedimentation rate, and increased absolute counts of peripheral blood lymphocyte subsets (all P < 0.05). The interleukin-1β (IL-1β) positivity rate was significantly higher in the relapse group than in the non-relapse group (P < 0.05). IL-1β positivity was significantly associated with an increased risk of disease relapse (odds ratio = 9.727, 95% confidence interval: 1.650-102.224, P = 0.012; area under the curve = 0.591; Brier score = 0.177). PNS relapse was positively correlated with increased IL-1β levels (r = 0.321, P = 0.005).
IL-1β positivity is associated with relapse within 6 months of onset in children with newly diagnosed PNS. Further studies are required to validate this association and elucidate the underlying mechanisms.

PMID:
42666322
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement